Rehabilitation and Chronic Care 2018
DOI: 10.1183/13993003.congress-2018.pa2047
|View full text |Cite
|
Sign up to set email alerts
|

Sertraline in symptomatic chronic breathlessness: a double blind, randomised trial

Abstract: Take Home Message Chronic breathlessness generates suffering late in life. In this setting, titrated sertraline had similar benefits and harms to placebo in an adequately powered, multi-site, double blind, randomised controlled trial at four weeks.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 29 publications
0
1
0
Order By: Relevance
“…Although our knowledge of the role of the brain in breathlessness perception has greatly increased in the last decade, this has not yet led to clinically applicable improvements for patients. In randomized controlled trials neither antidepressants nor anxiolytic drugs have been proven to alter the experience of patients with refractory breathlessness [12,13]. However, the viewpoint that traumatic breathlessness episodes may lead to PTSD symptoms which aggravate breathlessness, has not been explored before.…”
Section: Introductionmentioning
confidence: 99%
“…Although our knowledge of the role of the brain in breathlessness perception has greatly increased in the last decade, this has not yet led to clinically applicable improvements for patients. In randomized controlled trials neither antidepressants nor anxiolytic drugs have been proven to alter the experience of patients with refractory breathlessness [12,13]. However, the viewpoint that traumatic breathlessness episodes may lead to PTSD symptoms which aggravate breathlessness, has not been explored before.…”
Section: Introductionmentioning
confidence: 99%